Preclinical Antitumor Activity and Toxicity of the PSMA-Docetaxel Conjugate Substance in Comparison with Docetaxel In Vivo

Authors
Shchepin N.A. 1 , Machulkin A.E. 2 , Majouga A.G.2 , Smirnova G.B. , Borisova Y.A. , Pokrovsky V.S. 1
Conference proceedings
#SCIENCE4HEALTH2021
Publisher
Российский университет дружбы народов (РУДН)
Language
English
Pages
227-228
Status
Published
Year
2021
Organizations
  • 1 RUDN University
  • 2 M.V. Lomonosov Moscow State University
  • 3 N.N. Blokhin Cancer Research Center
Keywords
Prostatic neoplasms; prostate-specific membrane antigen; docetaxel; conjugates
Date of creation
11.07.2024
Date of change
11.07.2024
Short link
https://repository.rudn.ru/en/records/article/record/153849/
Share

Other records